NGM   $1.54  -0.64% Market Closed

NGM Biopharmaceuticals Inc
Total Cash 144.18M
totalCashPerShare 1.728
EBITDA -144.33M
Total Debt 0.00
quickRatio 7.183
currentRatio 7.791
Total Revenue 4.42M
debtToEquity
Revenue/Share 0.054
ROA -0.38462
ROE -0.69758004
grossProfits
freeCashflow -79.17M
operatingCashflow -132.20M
earningsGrowth
revenueGrowth -0.991
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -179.77576
profitMargins 0.0
enterpriseValue -8.98M
forwardPE -2.0533333
floatShares 28.89M
sharesOutstanding 83.46M
sharesShort 1.68M
sharesShortPriorMonth 1.66M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.21%
heldPercentInstitutions 0.54%
Short Ratio help_outline 1.26%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 1.793
Price To Book help_outline 0.86
earningsQuarterlyGrowth
netIncomeToCommon -142.38M
trailingEps -1.73%
forwardEps -0.75%
enterpriseToEbitda 0.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.46 1Q 2024
institutionsCount 116
lastUpdated April 16, 2024, 7:42 p.m.